Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Red currant, botanically known as *Ribes rubrum L.*, is a berry rich in various bioactive compounds, including flavonols, anthocyanins (such as cyanidin-3-O-glucoside and quercetin), linoleic acid, α-linolenic acid, tocopherols, and other phenolic compounds. It is valued for its nutritive and protective features and is explored for its potential health-promoting properties. Research indicates its use in functional foods and dietary supplements, demonstrating antioxidant, spasmolytic, and α-glucosidase inhibitory effects. The fruit's composition and beneficial properties can vary based on factors like geographical origin and processing methods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Red currant.